Predictors for hemorrhagic transformation with intravenous tissue plasminogen activator in acute ischemic stroke

Tokai Journal of Experimental and Clinical Medicine

Volumn 38, Issue 1, 2013, Pages 24-27

  Moriya, Yusuke ^a   Takahashi, Wakoh ^a   Kijima, Chikage ^a   Yutani, Sachiko ^a   Iijima, Eri ^a   Mizuma, Atsushi ^a   Honma, Kazunari ^a   Uesugi, Tsuyoshi ^a   Ohnuki, Yoichi ^a   Nagata, Eiichirou ^a   Yanagimachi, Noriharu ^a   Takizawa, Shunya ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cerebral microbleeds; Hemorrhagic transformation; Ischemic stroke; Magnetic resonance imaging; Recombinant tissue plasminogen activator

Indexed keywords

ALTEPLASE;

ADULT; AGED; ALBERTA STROKE PROGRAMME EARLY CT SCORE; ALBERTA STROKE PROGRAMME EARLY CT SCORE ON DIFFUSION WEIGHTED IMAGES SCORE; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOGENIC STROKE; CEREBROVASCULAR ACCIDENT; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENSITY GRADIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HEMORRHAGIC TRANSFORMATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE SCORE; ONSET AGE; PREDICTION; PREVALENCE; PROSPECTIVE STUDY; RADIODIAGNOSIS; RATING SCALE; RISK FACTOR; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; THROMBOSIS;

AGED; AGED, 80 AND OVER; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECOMBINANT PROTEINS; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84876374282     PISSN: 03850005     EISSN: 21852243     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hakim AM, Ryder-Cooke A, Melanson D. Sequential computerized tomographic appearance of strokes. Stroke 1983; 14: 893-897.
2. Hornig CR, Dorndorf W, Agnoli AL. Hemorrhagic cerebral infarction. - A prospective study. Stroke 1986; 17: 179-185.
3. Lodder J, Krune-Kubat B, Broekman J. Cerebral hemorrhagic infarction at autopsy: cardiac embolic cause and the relationship to the cause of death. Stroke 1986; 17: 626-629.
4. Okada Y, Yamaguchi T, Minematsu K, Miyashita T, Sawada T, Sadoshima S, et al. Hemorrhagic transformation in cerebral embolism. Stroke 1989; 20: 598-603.
5. Toni D, Fiorelli M, Bastianello S, Sacchetti ML, Sette G, Argentino C, et al. Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology 1996; 46: 341-345.
6. Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke. Stroke 1997; 28: 957-960.
7. Paciaroni M, Agnelli G, Corea F, Ageno W, Alberti A, Lanari A, et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome. Results of a prospective multicenter study. Stroke 2008; 39: 2249-2256
8. Selim M, Fink JN, Kumar S, Caplan LR, Horkan C, Chen Y, et al. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator. Prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke 2002; 33: 2047-2052.
9. Lansberg MG, Thijs VN, Bammer R, Kemp S, Wijman AC, Marks MP, et al. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke 2007; 38: 2275-2278.
10. Toyoda K, Koga M, Naganuma M, Shiokawa Y, Nakagawara J, Furui E, et al. Routine use of intravenous low-dose recombinant tissue plasminogen activator in Japanese patients. General outcomes and prognostic factors from the SAMURAI Register. Stroke 2009; 40: 3591-3595.
11. Nezu T, Koga M, Nakagawara J, Shiokaw Y, Yamagami H, Furui E, et al. Early ischemic change on CT versus diffusion-weighted imaging for patients with stroke receiving intravenous recombinant tissue-type plasminogen activator therapy. Stroke acute management with urgent risk-factor assessment and improvement (SAMURI) rt-PA registry. Stroke 2011; 42: 2196-2200.
12. Atlas SW, Mark AS, Grossman RI, Gomori JM. Intracranial hemorrhage: gradient-echo MR imaging at 1.5 T. Comparison with spin-echo imaging and clinical applications. Radiology 1988; 168: 803-807.
13. Tsushima Y, Aoki J, Endo K. Brain microhemorrhages detected on T2 -weighted gradient-echo MR images. Am J Neuroradiol 2003; 24: 88-96.
14. Wong KS, Chan YL, Liu JY, Gao S, Lam WW. Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages. Neurology. 2003; 60: 511-513.
15. Bokura H, Saika R, Yamaguchi T, Nagai A, Ouro H, Kobayashi S, et al. Microbleeds are associated with subsequent hemorrhagic and ischemic stroke in healthy elderly individuals. Stroke 2011; 42: 1867-1871.
16. Nighoghossian N, Hermier M, Adeleine P, Blanc-Lasserre K, Derex L, Honnorat J, et al. Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke. A gradientecho T2-weighted brain MRI study. Stroke 2002; 33: 735-742.
17. Fan YH, Zhang L, Lam WW, Mok VC, Wong KS. Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke. Stroke 2003; 43: 2459-2462.
18. Kidwell CS, Saver JL, Villablanca JP, Duckwiler G, Fredieu A,Gough K, et al. Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke. 2002; 33: 95-98.
19. Derex L, Nighoghossian N, Hermier M, Adeleine P, Philippeau F, Honnorat J, et al. Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI. Cerebrovasc Dis 2004; 17: 238-241.
20. Kakuda W, Thijs VN, Lansberg MG, Bammer R, Wechsler L, Kemp S, et al. Clinical importance of microbleeds in patients receiving IV thrombolysis. Neurology 2005; 65: 1175-1178.
21. Fiehler J, Albers GW, Boulanger JM, Derex L, Gass A, Hjort N, et al. Schellinger PD, Johannes Trenkler J. Bleeding Risk Analysis in Stroke Imaging Before ThromboLysis (BRASIL). Pooled analysis of T2 -weighted magnetic resonance imaging data from 570 patients. Stroke 2007; 38: 2738-2744.
22. Kawamura Y, Torihashi K, Sadamasa N, Yoshida K, Narumi O, Chin M, et al. Factors predicting intracerebral hemorrhage of patients treated with intravenous recombinant tissue plasminogen activator. Jpn J Stroke 2010; 32: 455-462.
23. Barber PA, Hill, Eliasziw M, Demchuk AM, Pexman JHW, Hudon ME, Tomanek A, Frayne R, Buchan AM. for the ASPECTS Study Group. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusionweighted imaging. J Neurol Neurosurg Psychiatry 2005; 76: 1528-1533.
24. Trouillas P, von Kummer R. Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke. Stroke 2006; 37:556-561.
25. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604-607.